CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies.

Item

http://www.wikidata.org/entity/Q38807514

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

CD20-targeting in B-cell malig ...... ies and combination therapies.

@en

type

Item

label

CD20-targeting in B-cell malig ...... ies and combination therapies.

@en

prefLabel

CD20-targeting in B-cell malig ...... ies and combination therapies.

@en

P1476

CD20-targeting in B-cell malig ...... ies and combination therapies.

@en

P2093

Vahideh Ahmadzadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4

CD20 deficiency in humans results in impaired T cell-independent antibody responses

Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies

Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig™) molecule

Sti1 is a non-competitive inhibitor of the Hsp90 ATPase. Binding prevents the N-terminal dimerization reaction during the atpase cycle.

The biology of CD20 and its potential as a target for mAb therapy

Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies.

The epitope recognized by rituximab.

Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.

P2888

s10637-016-0349-4

P304

497-512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10637-016-0349-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Safar Farajnia

Y Safdari

P577

2016-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1040928004

http://www.w3.org/2001/XMLSchema#string

P698

27075017

http://www.w3.org/2001/XMLSchema#string